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Background: Low- and middle-income countries (LMICs) are developing novel approaches to healthcare that may
be relevant to high-income countries (HICs). These include products, services, organizational processes, or policies
that improve access, cost, or efficiency of healthcare. However, given the challenge of replication, it is difficult to
identify innovations that could be successfully adapted to high-income settings. We present a set of criteria for
evaluating the potential impact of LMIC innovations in HIC settings.
Methods: An initial framework was drafted based on a literature review, and revised iteratively by applying it to LMIC
examples from the Center for Health Market Innovations (CHMI) program database. The resulting criteria were then
reviewed using a modified Delphi process by the Reverse Innovation Working Group, consisting of 31 experts in
medicine, engineering, management and political science, as well as representatives from industry and government, all
with an expressed interest in reverse innovation.
Results: The resulting 8 criteria are divided into two steps with a simple scoring system. First, innovations are assessed
according to their success within the LMIC context according to metrics of improving accessibility, cost-effectiveness,
scalability, and overall effectiveness. Next, they are scored for their potential for spread to HICs, according to their ability
to address an HIC healthcare challenge, compatibility with infrastructure and regulatory requirements, degree of
novelty, and degree of current collaboration with HICs. We use examples to illustrate where programs which appear
initially promising may be unlikely to succeed in a HIC setting due to feasibility concerns.
Conclusions: This study presents a framework for identifying reverse innovations that may be useful to policymakers
and funding agencies interested in identifying novel approaches to addressing cost and access to care in HICs. We
solicited expert feedback and consensus on an empirically-derived set of criteria to create a practical tool for funders
that can be used directly and tested prospectively using current databases of LMIC programs.
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There has always been an imperative to do more with
less in low- and middle-income countries (LMICs) in
general, but particularly in healthcare [1]. While invest-
ment in healthcare has been increasing for many of
these countries, the needs and challenges faced by
LMICs are greater than in high-income countries
(HICs), and the resources are much more limited [2, 3].1
The ability of LMIC organizations to innovate is facili-
tated by the absence of constraining legacy systems, a
flexible regulatory environment, low performance of
standard approaches, and an urgency to do things better
and cheaper [4]. As a result, many innovations that ori-
ginate in LMICs have been shown to reduce cost, im-
prove quality, and enhance access [5]. The relevance of
these innovations to HIC settings has only recently been
acknowledged, due to a growing pressure to control
costs and improve access for marginalized groups [4, 6,
7]. This has increased interest in shared learning about
innovations between low- and high-resource settings,[8]
and the adaptation of LMIC innovations to HICs has
been described as “reverse innovation” [4, 9]. While the
use of the term “reverse” is controversial, the opportun-
ities for HICs to learn from LMIC innovation are com-
pelling. This novel approach to harness LMIC
inventions in healthcare and life sciences could rapidly
generate promising options for developed countries,
overcoming some constraints to innovation in high-
income settings.
The potential for LMIC innovations in HICs in medical-
device and health product development, process-of-care
improvements, and policy innovations, is starting to be re-
alized. This is evidenced by such cases as General Electric
India’s $800 electrocardiogram, now sold in 194 countries
around the world [9]; the construction of Health City Cay-
man Islands, a 104-bed hospital using low-cost, high-
throughput methods based on Narayana Hrudayalaya’s
model in India [10]; adaptation of a community health
worker model from Kenya to New York City by City
Health Works [11, 12]; and implementation of the Oppor-
tunity NYC – Family Rewards program in New York,
inspired by Mexico’s Oportunidades conditional cash
transfer program [13]. Many of these initiatives have taken
hold, and some have struggled; the initial Opportunity
NYC program was discontinued, for instance, because of
high cost and marginal effects [14].
While the impact of specific innovations has varied,
their potential has garnered attention from a variety of
stakeholders in HICs. They seek improvements involving
efficiency in discovery [15], implementation of low-cost
innovations to manage rising costs and a shrinking tax
base, and reduction of barriers to moving products and
services across national boundaries. Those interested in
adapting LMIC innovations to HIC contexts includefunders such as the Robert Wood Johnson Foundation
and the Commonwealth Fund in the US [16, 17] and the
Tekes Finnish Funding Agency for Innovation [18].
Despite the limited number of current examples, the
pace of development of new products, processes, and
policies from LMICs that are relevant to HICs is only
going to increase, as disease patterns converge and
healthcare coverage in low-resource settings increases
[19]. With increased opportunities for funding and more
LMIC-HIC partnerships, the capacity to develop and test
new approaches from LMICs is rapidly growing [8].
However, replicating any innovation is challenging, and
replicating in a very different context even more so;
therefore, many factors must be considered in deciding
to implement a new health model. Unsuccessful efforts
such as the Opportunity NYC program underline such
risks. The literature on reverse innovation describes exam-
ples and processes for how to develop reverse innovations
[20], [9], with one article describing a competition for
selecting LMIC innovations to test in HIC settings devel-
oped on an ad hoc basis [21]. This presents a critical op-
portunity for standardizing an approach to the evaluation
of potential reverse innovations. To this end, we propose a
screening mechanism to identify and promote those inno-
vations from low- and middle-income markets with the
greatest potential for application in HICs.
Methods
Using an iterative, qualitative approach involving literature
review, primary case study testing, secondary database
review, and a modified Delphi process, we developed a
two-part screening tool to identify innovations with the
potential to improve care and/or reduce costs in HICs.
Literature review and initial criteria development
Initial development of the tool began with review of the
relevant literature around reverse innovation, using
search terms such as “reverse innovation”, “frugal
innovation”, “embedded innovation”, and “global health
innovation”. From this, we developed a candidate set of
11 criteria to test further and refine. We then shared
these initial criteria with six key informants in the global
health field, including researchers, funders and clinicians
based in HICs with extensive experience engaging with
and assessing Canadian and LMIC health innovations.
Based on their feedback, we revised the initial categories,
resulting in eight refined criteria.
Primary testing on case studies of innovative programs
Next, we applied the criteria to brief case studies we had
developed for four LMIC health programs in the CHMI
database [22] that our team had previously identified as
having potential for adaptation in HICs. This allowed us
to explore the relevance and utility of the eight criteria,
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scoring system and divided the eight criteria into two
steps:
a. Evaluation of the program’s success within the
LMIC context.
b. Evaluation of the program’s likelihood to be a
reverse innovation in an HIC.
Secondary testing with expanded sample of programs
We then tested the criteria on 60 programs in the Cen-
ter for Health Market Innovation database randomly
sampled within five categories: innovative products, ser-
vices, organizational structures, information and com-
munication technologies, and financial models. Through
this testing along with discussion and review of our find-
ings, we developed a set of nine criteria with revised def-
initions and refined cut-off scores to identify likely and
unlikely reverse innovations.
Expert consultation in modified Delphi process
The resulting nine criteria were reviewed by a Reverse
Innovation Working Group comprised of 31 experts in
medicine, engineering, management, and political sci-
ence, as well as representatives from government and in-
dustry, all with an expressed interest in reverse
innovation. Many of the members were judges in a na-
tional reverse innovation competition held in Canada in
2014 [21]. Feedback was solicited using a modified Del-
phi process, an approach used to facilitate communica-
tion and build consensus amongst a group of experts on
a particular topic [23]. This involved a first round of
feedback with the group convening in a teleconference
to provide open-ended feedback on the criteria. After-
wards, focused feedback requesting input on specific
questions was solicited electronically from the working
group. This feedback was used to revise the criteria,
which were then shared again along with another set of
focused questions that were discussed at an in-person
meeting with the working group. Feedback from this
group was again incorporated into the criteria, and these
revised criteria, including the scoring system and sug-
gested cut-offs scores, were shared with working group
members electronically, at which point we achieved
consensus.
Results
The resulting tool consists of 8 criteria divided into 2
steps with a simple scoring system.
Figure 1 presents the final scoring system, which con-
sists of two parts: success in the LMIC and the potential
for success in an HIC. The first part includes assess-
ments of accessibility, cost effectiveness, scalability, and
overall effectiveness in the LMIC. The total cut-off scoreof 10 is low to act as a coarse screen leading to the sec-
ond phase. The second part reviews the health chal-
lenge addressed by the innovation, the compatibility
with infrastructure and regulations, the novelty of the
innovation, and the receptivity for the innovation in
the HIC. The scores for this second part indicate
whether the innovation is likely or unlikely to be a
successful reverse innovation, or requires further
investigation.
Case examples
Tables 1 and 2 provide examples of application of the
criteria to two different programs drawn from the CHMI
database [22]. Canada is chosen as the target HIC for
these examples, as Canada was the primary location for
the majority of the authors.
The first program, the Uganda Health Information
Network (UHIN), provides community health workers
with an online information system and personal digital
assistants for recording health information [24]. The
Bloomberg Philanthropies Maternal Health Initiative
(BPMHI), on the other hand, trains health workers in
performing life-saving procedures in maternal health in
rural and remote areas of Tanzania [25].
UHIN has proven to be effective at improving health
workers’ capabilities to access information remotely
through a handheld digital device, leading to a score of 4
in Accessibility. It also has a proven ability to scale,
having expanded successfully to 175 health facilities,
therefore scoring 4 on Scalability. The program has
demonstrated impact through an independent evalu-
ation, which reported a 25% savings per patient visit unit
through the new information system, compared to the
original paper-based system, leading to a 5 on Cost Ef-
fectiveness. Thus, it has demonstrated some impact in
this area, and it is in the process of evaluating its
organizational performance and health system outcomes,
leading to a 3 for Effectiveness.
Moving to Step 2, UHIN’s main mandate, health infor-
mation integration and access to maternal healthcare, is
highly relevant to the current Canadian policy environ-
ment, leading to a score of 5 on Gap in Target HIC.
Given the general historical uncertainty of success asso-
ciated with IT-based healthcare initiatives, however,
UHIN scores a 3 in Compatibility with existing Canad-
ian infrastructure. Mobile phone technology to record
and store patient data in healthcare is relatively novel in
the Canadian context, leading to a 4 on Novelty. Finally,
UHIN is well-connected to Canadian partners, the Inter-
national Development Research Centre and the former
Canadian International Development Agency, leading to
a 4 in Receptivity. This leads to an overall score of 16,
with the conclusion that the program is likely to be
worth testing as a reverse innovation in Canada.
Fig. 1 Criteria Scoring System. 0 No information exists, or the criterion is not applicable. 1 Demonstration that this has not been achieved. 2
Uncertain or conflicting demonstration. 3 Some demonstration of achievement. 4 Strong demonstration of achievement. 5 Significant
demonstration of achievement. Definitions of Individual Criteria. Accessibility: Innovation increases access of products or services through
increasing financial, geographic and/or social access. Cost Effectiveness: Innovation improves cost effectiveness to payer, provider, or end user.
Scalability: Innovation increases scope, geographic cover, or customer base. Effectiveness: Documentation of effectiveness of innovation using
appropriate evaluative methods. Gap in Target HIC: Creating solutions for unsolved (or imperfectly solved) challenges or unaddressed health
issues or service gaps. Compatibility: Compatible with healthcare infrastructure in the target HIC country. Novelty: Innovation is a novel approach
or an established innovation used in a new way that has great promise. Receptivity: Openness and engagement of partners as well as those not
considered partners but who may be impacted by the innovation
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Health Initiative scores well in Step 1. The initiative has
improved access to healthcare for patients by upgrading
remote health centers while expanding the skill set of
midwives to include Cesarean sections, ostensibly im-
proving the access to this much-needed procedure, and
others, in rural areas, leading to a 5 on Accessibility.
Through task shifting, the initiative has lower costs com-
pared to staffing with physicians or long distance ambu-
lance transportation, leading to a 4 on Cost-Effectiveness
and Efficiency. The program has also demonstrated its
scalability through its expansion from 9 to 12 sites, giv-
ing it a 4 on Scalability. At the same time, unlike the
first initiative’s independent evaluation, BPMHI lacks
specific data that measures the program’s impact, leading
to a score of 2 on Effectiveness.
However, through Step 2, we find that UHIN has a
much higher likelihood of success as a reverse innovationcompared to BPMHI. The initiative certainly addresses an
important gap in Canada, the accessibility of maternal
healthcare in remote rural areas, scoring 4 on Gap in Tar-
get HIC, and uses a novel approach, scoring 3 on Novelty.
Despite these positives, current Canadian regulation on
scope of practice precludes midwives from doing surgery,
leading to a rating of 1 on Compatibility. The program
also lacks connections with existing Canadian partners,
giving it a 1 on Receptivity. Given its overall rating of 9,
the Bloomberg Philanthropies Maternal Health Initiative
does not pass final round screening, and thus would not
be further considered for further testing and adaptation
into Canada.
Discussion
The increasing pace of innovation in LMICs and the ris-
ing interest in cost control in HICs suggests that the
value of systematically screening promising ideas from
Table 1 Applying the Reverse Innovation Criteria: Uganda Health Information Network (UHIN)
Brief description of initiative: An information network for community health workers using low-cost PDAs and cellular networks to collect and share critical
health data
Step 1
Criteria Description Score Rationale
1. Accessibility Innovation increases access of products or services
through increasing affordability, geographic access,
and/or social access.
4 The program provides community health workers with PDAs
that automatically load public health data to a centralized
data bank. This helps with disease surveillance to ensure the
right medicines and services are directed where needed.
2. Cost Effectiveness Innovation improves cost effectiveness to payer,
provider, or end user.
5 A study by independent consultants reported a savings of
25% per unit compared to traditional manual paper data
collection.
3. Scalability Innovation increases scope, geographic cover, or
customer base.
4 There are 700 health workers in the program. There are 175
remote health facilities in the country that now have PDA
capability, serving 1.5 million people.
4. Effectiveness Documentation of effectiveness of innovation using
appropriate evaluative methods
3 The cost-effectiveness of the program has been evaluated
by independent consultants. The program is currently evalu-
ating its health impact on healthcare planning, resource allo-
cation, and delivery.
TOTAL SCORE 16 Conclusion: Move to Step 2
Step 2
Criteria Description Score Rationale
5. Gap in Target HIC Creating solutions for unsolved (or imperfectly
solved) challenges or unaddressed health issues or
service gaps.
5 Information integration and digitalization, with particular
attention to cost control, are extremely important challenges
for the Canadian health system.
6. Compatibility Compatible with healthcare infrastructure in the
target HIC.
3 It is unclear how this information system would be
regulated in the Canadian context, particularly with privacy
considerations. However, the system could likely be adapted
to meet Canadian regulations.
7. Novelty The innovation is a novel approach or an
established innovation used in a new way that has
great promise.
4 PDAs and smartphones remain a relatively innovative,
uncommon tool for health data collection in Canada.
8. Receptivity Openness and engagement of partners as well as
those not considered partners but who may be
impacted by the innovation.
4 The IDRC and former CIDA are the primary funders of this
initiative, suggesting strong connections to Canada.
TOTAL SCORE 16 Conclusion: Score is ≥16. Likely to be a reverse innovation.
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time. This paper describes a screening tool to rapidly as-
sess promising LMIC innovations for adaptation in HICs
and identify those with high potential for more in-depth
review and evaluation. It highlights (but does not resolve)
the tradeoff between high-potential radical innovations,
which are difficult to implement, and incremental innova-
tions that provide “easy wins.” It also highlights challenges
in adapting LMIC innovations to HICs, including differ-
ences in scope of practice, quality concerns, and regu-
latory issues. It was developed with a broad range of
experts from different sectors, and field tested for rele-
vance to products, organizational processes, and pol-
icies. While our tool does not solve the challenge of
adaptation from a low to high resource setting, it can
help decide whether an approach is worth pursuing
despite the barriers. It does so by including criteria for
impact, cost, access, technical feasibility, and alignment
with public policy.Screening for reverse innovations may be useful for
public, private, for-profit, and nonprofit organizations,
particularly those that are interested in affordable ap-
proaches to meet the needs of marginalized or hard to
reach groups. We envision that the metrics incorporated
in the tool may be useful to a variety of stakeholders, in-
cluding: multinational corporations, such as the
Innovation Managers at Xerox who canvass Indian start-
ups for innovations that may be implemented in their glo-
bal operations [26]; health-care institutions, such as the
Commonwealth Fund’s Innovation Collaborative, which
brings together large health systems seeking novel ap-
proaches to increase efficiency; and governmental bodies,
such as the New York City Council, which adapted Mexi-
co’s conditional cash transfer program. For these stake-
holders, the process of reverse innovation could be
accelerated by using the criteria to screen databases for
low-cost, high-yield innovations like the over 1300 pro-
grams listed in the CHMI database [22], the over 600
Table 2 Applying the Reverse Innovation Criteria: Bloomberg Philanthropies Maternal Health Initiative (BPMHI)
Brief description: The program trains assistant medical officers and midwives in remote areas to perform life-saving procedures including caesarean sections
and upgrades isolated health centers
Step 1
Criteria Description Score Rationale
1. Accessibility Innovation increases access of products or services
through increasing affordability, geographic access,
and/or social access.
5 The program has upgraded 9 remote health centers,
increasing geographic access to services provided locally;
prior to the program, patients had to travel 3-4 hours to the
nearest hospital.
2. Cost Effectiveness Innovation improves cost effectiveness to payer,
provider, or end user.
4 Indirectly, the program has improved cost effectiveness by
"up-training" midwives to perform more complex tasks such
as c-sections, reducing the need for more costly healthcare
providers.
3. Scalability Innovation increases scope, geographic cover, or
customer base.
4 Since inception, the program has increased its coverage
from 9 sites to 12, and has been expanding to e-Learning
platforms in 2013. Deliveries at all intervention hospitals have
increased from 3,500 deliveries per year before the program
to 9,000 deliveries per year after the program launch.
4. Effectiveness Documentation of effectiveness of innovation using
appropriate evaluative methods.
3 One district where the program operates experienced a 32%
decline in maternal deaths after the program was
implemented. However, information on evalulation
techniques and reporting on impact for all sites is limited.
TOTAL SCORE 16 Conclusion: Move to Step 2
Step 2
Criteria Description Score Rationale
5. Gap in Target HIC Creating solutions for unsolved (or imperfectly
solved) challenges or unaddressed health issues or
service gaps.
4 Access to quality maternity care services, particularly in rural
and northern areas, is an important healthcare issue in
Canada.
6. Compatibility Compatible with healthcare infrastructure in the
target HIC.
1 Midwives and physician assistants play a limited role in
Canada as of present. Implementation of such a program
would challenging given current regulations and staffing
levels.
7. Novelty The innovation is a novel approach or an
established innovation used in a new way that has
great promise.
3 Midwifery and physician-assistant - performed c-sections are
quite a novel concept; however refurbishing rural hospitals is
not.
8. Receptivity Openness and engagement of partners as well as
those not considered partners but who may be
impacted by the innovation.
1 This initiative does not involve Canadian partners or
Canadian stakeholders.
TOTAL SCORE 9 Conclusion: Score is ≤10. Unlikely to be a reverse innovation.
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almost 100 examples in the World Innovation Summit for
Health Innovation Network database [28]. Having a stand-
ard screening tool can help to proactively obtain the ap-
propriate information from potential innovations and
inform the further development of these databases. To
this end, these criteria were tested for inter-rater reliability
using a detailed dataset on innovations compiled by Im-
perial College in the United Kingdom for consideration by
US delivery systems.
The strengths of this study include its multidisciplin-
ary perspective, and its iterative development using nu-
merous case examples, which contrast with the more
ad hoc nature of previous work. The limitations include
the narrow focus on application to the Canadian context,
which may limit generalizability to other settings, the use
of abstract concepts like compatibility, which may besubjective and limit agreement on how to assess each par-
ameter, and finally, the limited data on the programs
under study. The scores for each category are based on
how strongly a program has demonstrated achievement in
each area. While the scoring system and the cut-off scores
were developed through several rounds of testing and feed-
back, there is some subjectivity in determining the scores
for programs. The tool can be strengthened through further
testing and standardization, which is currently ongoing at
Imperial College. Next steps in this area would include test-
ing in a country context other than Canada, and prospect-
ively assessing the success of implementing innovations
which scored higher with this tool with others having lower
scores. The work of the Innovation Collaborative in the US,
which has chosen 3 innovations to implement, can help to
further this area of research, but more examples will be
needed to assess the validity of the tool.
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portant first step, but replication also requires identify-
ing the key ingredients or efficiency core of an
intervention, a process requiring more in-depth investi-
gation [29]. CHMI has a tool to assist with this, looking
at what makes the intervention work and its key con-
textual factors [30]. The University of California at Los
Angeles’ Global Lab for Innovation has also drafted elab-
orate criteria to evaluate cost-saving innovations from
across the globe with the aim of identifying and piloting
these innovations within their health system [31]. To-
gether, these tools help map the first steps in a complex
process that draws on the ingenuity of people in low-
resource settings as a source of new ideas for high-
income settings, increasing the likelihood that they could
have an impact.
Conclusion
Diligent application of a tool to identify innovations from
low-resource settings that improve affordability, access or
quality could provide a range of options to improve the
economics of healthcare in high-cost countries. As experi-
ence grows and more data becomes available, the tool can
be refined and made more generalizable for the benefit of
health organizations and decision makers worldwide.
Once promising strategies are identified, the challenge of
adapting innovations from LMICs to HICs remains, with
opportunities for future research into the approaches that
generate performance differences in translation itself. As
the number of potential reverse innovations increase, a
rapid screen should be followed by efforts to identify key
components and contextual factors to increase their up-
take and impact both in high- and low-income countries.
Endnote
1We use the terms HIC and LMIC as described by the
World Bank (https://datahelpdesk.worldbank.org/knowl-
edgebase/articles/906519), which provides country cat-
egories based on gross national income (GNI) per capita.
We make a distinction between HICs (those with a GNI
per capita of $12,476 or more), and LMICs (those with a
GNI per capita below $12,476).
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